≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other and unspecified disorders of psychological development

EFO MESH Endpoint Browser PheWeb

F5_PSYCHDEVOTH

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F88, F89
  • Hospital discharge: ICD-9 — 3159
  • Cause of death: ICD-10 — F88, F89
  • Cause of death: ICD-9 — 3159

2 out of 7 registries used, show all original rules.

499

4. Check minimum number of events

None

499

5. Include endpoints

None

499

6. Filter based on genotype QC (FinnGen only)

431

Control definitions (FinnGen only)

Control exclude
F5_PSYCHDEV

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 11758 3380 8372
Only index persons 8924 2658 6266
Unadjusted period prevalence (%)
Whole population 0.19 0.10 0.23
Only index persons 0.20 0.10 0.24
Median age at first event (years)
Whole population 8.17 8.75 7.94
Only index persons 9.13 9.99 8.76

-FinnGen-

Key figures

All Female Male
Number of individuals 431 174 257
Unadjusted period prevalence (%) 0.10 0.06 0.12
Median age at first event (years) 9.80 12.41 8.03

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
468
Matched controls
4530
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F88
ICD-10 Finland
Other disorders of psychological development
484.8
214.8
201
7
F89
ICD-10 Finland
Unspecified disorder of psychological development
658.9
211.5
196
5
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
13.7
119.8
129
122
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
+∞
116.4
108
*
IGV01
NOMESCO Finland
Psychiatric network contact
17.5
112.0
101
70
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
10.2
107.2
148
197
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
9.6
96.1
136
185
IGP01
NOMESCO Finland
Psychiatric family contact
12.3
94.5
106
105
IGY99
NOMESCO Finland
Other psychiatric treatment contact
10.3
91.8
120
147
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
25.9
88.7
65
28
ICB06, ,
NOMESCO Finland
17.7
78.3
68
43
N05AX08
ATC
risperidone; systemic
9.1
77.5
110
148
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
11.8
74.1
83
81
F83
ICD-10 Finland
Mixed specific developmental disorders
386.0
69.7
69
*
IEV99
NOMESCO Finland
Other psychiatric network intervention
16.0
66.9
61
42
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
8.5
66.5
98
137
Z2445
NOMESCO Finland
Psychologist
7.1
66.3
119
207
ZY010
NOMESCO Finland
Hospital outpatient
6.8
65.1
124
229
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
8.8
63.4
90
120
IEP99
NOMESCO Finland
Other psychiatric family intervention
13.7
61.3
61
49
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
9.9
59.3
75
86
F90.0
ICD-10 Finland
Disturbance of activity and attention
5.3
57.8
151
371
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
13.5
57.0
57
46
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
13.9
56.9
56
44
N05AX12
ATC
aripiprazole; systemic
7.3
53.7
90
144
IEP03
NOMESCO Finland
Focused parental counselling
10.2
52.8
64
69
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
6.2
50.2
101
194
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
7.0
50.0
86
141
F84.8
ICD-10 Finland
Other pervasive developmental disorders
+∞
49.3
47
*
ZYC01
NOMESCO Finland
Remote contact by phone
6.5
48.5
91
163
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.4
48.1
168
513
F84.5
ICD-10 Finland
Asperger syndrome
94.2
47.3
52
6
XA800
NOMESCO Finland
Neuropsychological investigation
7.5
46.6
74
111
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.7
46.2
100
205
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
132.1
46.1
49
*
R62.0
ICD-10 Finland
Delayed milestone
11.4
46.1
51
48
IGY02
NOMESCO Finland
Psychiatric monitoring contact
5.5
45.5
105
228
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
11.2
45.4
51
49
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
6.3
43.0
81
145
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.2
41.1
79
144
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.5
40.7
125
342
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
6.0
40.6
81
153
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.1
40.0
98
223
F82
ICD-10 Finland
Specific developmental disorder of motor function
114.3
39.9
43
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
10.0
39.8
48
51
N05AH03
ATC
olanzapine; systemic
5.5
39.8
88
183
N06BA04
ATC
methylphenidate; oral
4.4
39.6
122
334
Z2446
NOMESCO Finland
Social worker
4.2
38.5
127
365
IER01
NOMESCO Finland
Psychoeducation, group
12.0
37.7
40
35
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
9.4
37.2
47
53
N03AG01
ATC
valproic acid; systemic, rectal
6.0
36.8
72
133
F93.89
ICD-10 Finland
Other childhood emotional disorders
8.0
35.3
51
68
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
8.1
34.9
50
66
F29
ICD-10 Finland
Unspecified nonorganic psychosis
5.8
34.0
68
128
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
13.1
33.1
33
26
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
121.8
32.7
35
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.9
31.6
78
177
F80.1
ICD-10 Finland
Expressive language disorder
114.3
30.7
33
*
IEP02
NOMESCO Finland
Child-centred family therapy
6.4
30.5
54
90
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.5
30.4
64
126
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
+∞
30.2
29
*
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
5.1
29.5
69
149
Z3226
NOMESCO Finland
Physiotherapist
3.3
29.1
150
570
Z2221
NOMESCO Finland
Medical doctor
3.1
28.8
180
765
R5599
NOMESCO Finland
Other rehabilitation service
8.0
28.6
41
54
N05AH04
ATC
quetiapine; oral
3.3
28.0
140
521
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
66.3
27.9
32
5
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.3
27.2
60
123
Z3231
NOMESCO Finland
Registered nurse
2.8
26.4
212
1024
F84.0
ICD-10 Finland
Childhood autism
+∞
26.0
25
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.9
25.1
86
249
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
5.8
25.0
49
90
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
6.8
24.9
41
63
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.2
23.9
115
414
F80.2
ICD-10 Finland
Receptive language disorder
127.5
23.5
25
*
N03AX09
ATC
lamotrigine; oral
4.7
22.9
57
129
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
122.2
22.5
24
*
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
+∞
20.7
20
*
T82
ICPC
Obesity
5.8
19.8
38
68
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
74.5
19.6
22
*
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
40.7
19.4
24
6
F20.9
ICD-10 Finland
Schizophrenia, unspecified
7.4
19.3
29
40
R4120
NOMESCO Finland
Occupational therapy
4.3
19.0
52
127
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.2
18.5
40
80
IEP01
NOMESCO Finland
Psychoeducation, family
8.2
18.2
25
31
P99
ICPC
Psychological disorders other
5.1
18.0
40
82
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
5.8
18.0
34
60
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.6
17.8
64
190
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
27.1
17.7
24
9
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
15.1
17.0
28
19
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
15.3
16.5
27
18
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
13.6
16.3
28
21
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.6
16.1
32
59
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
6.5
16.1
27
42
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.6
15.7
26
40
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.6
15.0
53
155
EBA15
NOMESCO Finland
Extraction of multiple teeth
5.0
14.7
33
68
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
13.4
14.6
25
19
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
+∞
14.5
14
*
N05AH02
ATC
clozapine; systemic
6.0
14.3
26
44
N05AA02
ATC
levomepromazine; systemic
6.0
14.3
26
44
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
22.4
14.1
20
9
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
42.5
14.0
17
*
P22
ICPC
Child behaviour symptom/complaint
3.3
13.8
56
179
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
6.7
13.6
22
33
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.3
13.6
56
181
N05BA06
ATC
lorazepam; systemic, sublingual
6.1
13.4
24
40
Z50.5
ICD-10 Finland
Speech therapy
4.0
13.3
39
100
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
13.1
110
515
ZXY60
NOMESCO Finland
2-person team, nurses
15.1
13.0
21
14
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
11.1
12.9
24
22
N06AB03
ATC
fluoxetine; oral
3.0
12.8
61
215
P29
ICPC
Psychological sympt/compl other
2.5
12.6
90
391
N05BA01
ATC
diazepam; systemic, rectal
3.3
12.6
51
163
Z3229
NOMESCO Finland
Other healthcare associate professional
2.9
12.5
63
229
N06AB06
ATC
sertraline; oral
2.6
12.3
79
326
RT150, ,
NOMESCO Finland
11.7
12.2
22
19
SPAT1389
SPAT
Visit based on need for special support
2.7
12.2
71
279
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.7
12.1
70
274
A28
ICPC
Limited function/disability NOS
3.3
12.0
49
157
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
4.1
12.0
34
85
G47.3
ICD-10 Finland
Sleep apnoea
2.7
11.9
70
276
F81.0
ICD-10 Finland
Specific reading disorder
21.3
11.9
17
8
F90.8
ICD-10 Finland
Other hyperkinetic disorders
21.3
11.9
17
8
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.6
11.6
72
291
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
10.6
11.6
22
21
N06AB04
ATC
citalopram; systemic
2.8
11.6
63
238
ZY000
NOMESCO Finland
Hospital inpatient
5.4
11.4
23
43
RL140, ,
NOMESCO Finland
13.6
11.3
19
14
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.8
11.3
26
55
RT420, ,
NOMESCO Finland
34.8
11.1
14
*
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
4.2
10.9
30
73
N05AB03
ATC
perphenazine; systemic, rectal
5.2
10.9
23
45
R4130
NOMESCO Finland
Speech therapy
4.8
10.6
24
50
RL130, ,
NOMESCO Finland
11.2
10.4
19
17
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
32.3
10.2
13
*
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
18.7
10.1
15
8
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.9
10.0
49
175
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
10.0
41
132
XA820, ,
NOMESCO Finland
14.5
9.9
16
11
P24
ICPC
Specific learning problem
3.5
9.8
35
103
N06AX16
ATC
venlafaxine; oral
2.5
9.8
67
284
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
12.1
9.7
17
14
N03AF02
ATC
oxcarbazepine; oral
3.8
9.7
30
80
ZXY58
NOMESCO Finland
2-person team, nurse-occupational therapist
54.4
9.5
11
*
RS140, ,
NOMESCO Finland
13.3
9.5
16
12
OAB43, ,
SPAT
0.5
9.5
82
1435
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.9
9.4
21
43
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
8.4
9.4
20
24
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
9.3
63
265
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
98.7
9.3
10
*
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
+∞
9.3
9
*
N05AF03
ATC
chlorprothixene; systemic
5.3
9.3
19
36
ZXY02
NOMESCO Finland
Neuropsychologist
12.3
9.2
16
13
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.5
9.2
61
255
T90
ICPC
Diabetes non-insulin dependent
3.0
9.1
41
139
IAB03
NOMESCO Finland
Neuropsychiatric consultation
36.3
8.9
11
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.2
8.9
88
437
OAA43, ,
SPAT
2.6
8.8
53
211
IGY02, ,
SPAT
4.6
8.7
21
46
N05BA09
ATC
clobazam; oral
6.8
8.7
21
31
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.3
8.7
33
101
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
10.6
8.7
16
15
183
Kela drug reimbursment
Lamotrigin and topiramate
7.6
8.5
19
25
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.8
8.5
26
69
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
11.5
8.4
15
13
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
6.9
8.4
20
29
P85
ICPC
Mental retardation
8.9
8.4
17
19
RT120, ,
NOMESCO Finland
27.2
8.4
11
*
ZYB05
NOMESCO Finland
Outreach service at patient’s workplace, school or occupational/school health care
19.8
8.4
12
6
F81.1
ICD-10 Finland
Specific spelling disorder
88.7
8.3
9
*
ZXY03
NOMESCO Finland
Occupational therapist
12.7
8.3
14
11
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.6
8.2
48
188
R1260
NOMESCO Finland
Evaluation of communicative skills
8.5
8.2
17
20
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.2
8.1
33
106
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
4.9
8.0
18
37
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
8.0
96
512
N04AA02
ATC
biperiden; systemic
11.6
8.0
14
12
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.0
7.9
36
123
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.7
7.9
42
157
P72
ICPC
Schizophrenia
4.7
7.8
18
38
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.8
7.8
41
152
N03AX14
ATC
levetiracetam; systemic
4.0
7.8
22
55
S29
ICPC
Skin symptom/complaint other
2.0
7.7
99
540
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
10.7
7.7
14
13
N03AF01
ATC
carbamazepine; oral, rectal
6.9
7.6
18
26
3459X
ICD-9 Finland
Epilepsy, unspecified
44.3
7.6
9
*
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
44.3
7.6
9
*
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.4
7.6
19
43
Z71.8
ICD-10 Finland
Other specified counselling
1.7
7.6
189
1268
P74
ICPC
Anxiety disorder/anxiety state
2.5
7.6
48
196
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
7.6
46
184
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.8
7.5
38
138
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
18.1
7.5
11
6
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
18.1
7.5
11
6
R32
ICD-10 Finland
Unspecified urinary incontinence
6.7
7.5
18
27
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
7.4
84
438
N05BA04
ATC
oxazepam; oral
2.0
7.4
87
460
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
7.1
7.4
17
24
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
7.6
7.3
16
21
ZYB06
NOMESCO Finland
Outreach service in patient's nursery
+∞
7.2
7
*
A29
ICPC
General symptom/complaint other
2.2
7.2
65
310
F91.3
ICD-10 Finland
Oppositional defiant disorder
10.7
7.2
13
12
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
9.3
7.2
14
15
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
15.5
7.1
11
7
RT490, ,
NOMESCO Finland
15.5
7.1
11
7
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
6.2
7.1
18
29
R1250
NOMESCO Finland
Evaluation of functional capability
6.2
7.1
18
29
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.6
7.1
43
172
C02AC02
ATC
guanfacine; oral
19.7
7.0
10
5
AA1AD
NOMESCO Finland
CT of head and brain
2.2
7.0
64
307
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
3.8
7.0
21
55
Z07
ICPC
Education problem
3.8
7.0
21
55
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.3
6.9
18
42
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.3
6.9
18
42
Z61.8
ICD-10 Finland
Other negative life events in childhood
9.9
6.9
13
13
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
6.9
6.9
16
23
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
6.9
80
421
P06
ICPC
Sleep disturbance
2.1
6.8
69
344
R4110
NOMESCO Finland
Physiotherapy
1.8
6.8
121
731
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.9
6.8
91
502
K03.66
ICD-10 Finland
Tooth plaque
2.0
6.8
78
408
DFF00
NOMESCO Finland
Pure tone audiometry
2.9
6.8
32
112
A06AD11
ATC
lactulose; oral
2.8
6.7
35
129
N17
ICPC
Vertigo/dizziness
2.4
6.7
48
207
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
10.8
6.7
12
11
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
39.4
6.7
8
*
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
39.4
6.7
8
*
R4170
NOMESCO Finland
Therapy forms involving educational rehabilitation
22.2
6.6
9
*
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
22.2
6.6
9
*
IAZ99
NOMESCO Finland
Other psychiatric consultation
7.1
6.6
15
21
Z29.8
ICD-10 Finland
Other specified prophylactic measures
2.8
6.6
34
125
RS222, ,
NOMESCO Finland
6.4
6.5
16
25
N06AX11
ATC
mirtazapine; oral
1.8
6.5
111
662
RT160, ,
NOMESCO Finland
7.7
6.5
14
18
Z31.5
ICD-10 Finland
Genetic counselling
2.4
6.5
46
198
ZXE00
NOMESCO Finland
One hour or less
1.7
6.5
180
1232
E66.9
ICD-10 Finland
Obesity, unspecified
3.5
6.4
22
63
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
9.9
6.4
12
12
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
68.5
6.4
7
*
RT130, ,
NOMESCO Finland
14.1
6.3
10
7
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.7
6.3
35
134
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
6.5
6.2
15
23
A10BA02
ATC
metformin; oral
2.3
6.2
49
221
ZXE22
NOMESCO Finland
Procedure duration at least 4 but less than 5 hours
10.9
6.2
11
10
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
+∞
6.2
6
*
3154A
ICD-9 Finland
Specific delays in development, Coördination disorder
+∞
6.2
6
*
N05AD01
ATC
haloperidol; systemic
5.9
6.2
16
27
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
9.1
6.2
12
13
F80.0
ICD-10 Finland
Specific speech articulation disorder
9.1
6.2
12
13
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.7
6.2
32
118
H81
ICPC
Excessive ear wax
2.3
6.1
46
203
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.4
6.1
41
172
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
6.0
30
108
E66.8
ICD-10 Finland
Other obesity
3.1
6.0
25
81
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.9
6.0
28
97
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
5.7
6.0
16
28
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
6.0
94
545

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
264
1669
2.22
15.71
3.5
2.4
—
—
—
0
0
217
1326
2.09
13.43
7.7
8.3
—
—
—
0
0
114
552
2.32
12.56
1.6
1.4
17.62
19.05
nmol/l
0.57
105
501
189
1140
2.01
11.71
4.4
4.6
34.17
32.88
u/l
0.14
180
1091
244
1617
1.96
11.45
8.8
10.8
1.22
1.22
mmol/l
0.07
232
1491
358
2717
2.17
11.41
5.1
3.8
14.43
14.56
pmol/l
0.46
343
2542
416
3387
2.70
10.86
17.9
12.0
139.51
139.45
mmol/l
0.22
410
3299
416
3390
2.69
10.79
17.7
12.0
3.92
3.93
mmol/l
0.60
410
3285
22
42
5.27
10.67
30.4
31.0
1361.23
1299.71
nmol/l
0.16
22
42
321
2371
1.99
10.58
14.5
11.7
3.75
3.64
e9/l
0.40
267
1969
223
1476
1.88
10.09
3.7
3.6
66.55
68.86
nmol/l
0.65
217
1410
160
957
1.94
9.81
4.2
5.0
7.93
8.70
mmol/l
0.98
154
899
338
2575
1.97
9.74
4.7
2.8
5.78
5.52
mmol/l
1.89
325
2381
140
806
1.97
9.56
2.9
2.9
52.72
58.27
u/l
0.96
134
762
59
238
2.60
9.53
3.4
3.6
—
—
—
0
0
296
2170
1.87
9.45
6.8
6.5
109.05
104.45
u/l
0.49
287
2063
389
3149
2.16
9.00
6.1
4.4
1.92
1.84
mu/l
0.88
377
2992
180
1145
1.85
8.97
5.4
8.1
37.48
38.14
g/l
0.81
174
1102
58
246
2.46
8.43
2.2
1.7
500.51
304.46
mu/l
1.73
51
226
294
2192
1.80
8.43
9.5
9.7
0.04
0.04
e9/l
0.28
240
1831
123
707
1.93
8.29
3.6
4.5
7.39
7.39
ph
0.44
79
478
300
2262
1.79
8.15
10.2
10.4
0.19
0.22
e9/l
1.53
254
1925
142
865
1.85
7.96
2.6
3.1
2.40
2.38
mmol/l
0.69
135
809
292
2197
1.76
7.86
9.5
9.7
0.57
0.56
e9/l
0.21
241
1836
229
1610
1.74
7.84
8.1
9.9
—
—
—
0
0
201
1372
1.73
7.58
6.0
7.3
17.72
17.23
umol/l
0.07
190
1296
144
893
1.81
7.56
2.1
1.7
97.67
95.37
pmol/l
0.26
84
502
261
1917
1.72
7.51
8.6
6.9
6.17
6.24
mmol/l
0.16
249
1770
274
2063
1.69
6.98
12.6
11.4
0.00
0.00
e9/l
1.08
216
1576
14
16
8.69
6.93
4.0
5.2
403.00
180.00
umol/l
—
7
7
118
705
1.83
6.92
5.0
9.8
7.38
7.37
ph
0.56
77
473
143
915
1.74
6.61
2.9
3.2
2.83
2.48
mg/l
0.56
131
825
294
2273
1.68
6.61
9.7
9.6
2.38
2.28
e9/l
0.82
247
1964
66
330
2.09
6.49
14.5
13.7
1.40
1.40
mmol/l
0.01
66
323
116
702
1.80
6.48
5.0
9.7
1.10
1.02
mmol/l
0.11
91
575
12
13
9.14
6.18
1.7
2.8
22.99
16.73
umol/l
0.58
12
13
47
209
2.31
6.16
1.5
1.5
902.10
1082.88
nmol/l
0.67
39
165
271
2074
1.63
6.14
9.9
9.8
0.65
0.65
%
0.07
256
2001
194
1368
1.64
6.13
5.3
5.2
14.07
29.43
e6/l
1.49
124
894
422
3665
2.17
5.97
12.0
9.4
32.98
28.58
u/l
1.08
413
3578
66
345
1.99
5.74
15.9
12.1
104.45
105.30
mmol/l
0.85
66
345
202
1456
1.60
5.73
3.1
3.2
6.36
6.27
ph
0.49
99
735
271
2095
1.60
5.71
9.9
9.7
8.19
8.39
%
0.77
257
2018
270
2086
1.60
5.70
9.9
9.7
2.81
3.27
%
2.57
255
2009
71
386
1.92
5.52
4.2
3.7
—
—
—
0
0
106
653
1.74
5.50
11.8
10.7
—
—
—
0
0
67
361
1.93
5.34
1.3
1.8
—
—
—
0
0
165
1149
1.60
5.32
4.3
4.3
12.25
94.94
e6/l
0.81
121
856
153
1047
1.62
5.30
4.1
4.1
0.15
0.21
e6/l
0.43
109
755
83
484
1.80
5.17
1.9
1.7
—
—
—
0
0
19
59
3.21
4.94
2.6
2.3
—
—
—
0
0
110
706
1.66
4.86
3.7
3.2
603.67
579.43
mosm/kgh2o
0.40
95
624
79
463
1.78
4.83
3.7
4.1
85.30
90.39
mg/l
0.03
58
343
307
2498
1.55
4.75
5.4
3.9
36.87
36.40
mmol/mol
0.31
297
2402
276
2197
1.53
4.70
9.9
9.4
34.54
34.11
%
0.25
263
2135
270
2150
1.51
4.51
9.6
9.4
50.33
50.89
%
0.29
260
2098
129
876
1.59
4.51
8.2
6.0
1.09
1.14
inr
0.40
105
724
36
164
2.22
4.49
24.8
15.6
126.75
124.80
g/l
0.19
36
158
19
63
3.00
4.45
6.9
8.3
—
—
—
0
0
62
347
1.84
4.40
2.0
2.0
2.41
2.41
mmol/l
0.07
53
305
21
474
0.40
4.27
1.1
1.3
—
—
—
0
0
76
457
1.73
4.25
4.5
4.7
4.67
46.15
mg/mmol
0.65
54
329
101
657
1.62
4.19
8.6
8.1
7.40
7.41
ph
0.90
84
545
41
211
1.97
3.75
22.1
14.4
1.11
0.38
mmol/l
0.61
36
179
38
191
2.01
3.72
23.7
15.6
91.89
95.55
%
0.64
38
185
41
212
1.96
3.71
22.5
14.4
7.40
7.40
ph
0.05
19
78
41
212
1.96
3.71
21.1
14.3
12.08
15.19
kpa
2.79
41
203
41
212
1.96
3.71
21.2
14.4
5.37
5.29
kpa
0.19
41
203
63
935
0.60
3.56
1.8
2.0
—
—
—
0
0
306
2565
1.45
3.50
4.2
3.0
1.30
1.17
mmol/l
1.60
298
2439
97
653
1.55
3.45
3.6
3.8
1.20
1.68
e6/l
0.47
51
336
108
752
1.51
3.28
3.6
3.4
10.02
5.66
e6/l
1.54
96
672
71
449
1.63
3.28
3.2
2.6
—
—
—
0
0
329
2812
1.45
3.26
4.9
3.4
4.32
4.53
mmol/l
4.38
322
2707
90
1197
0.66
3.07
2.9
2.1
—
—
—
0
0
20
400
0.46
3.01
1.4
1.6
2.96
3.37
mmol/l
—
7
262
326
2801
1.42
2.98
5.1
3.4
2.65
2.77
mmol/l
1.88
318
2676
18
74
2.41
2.88
4.6
10.4
—
—
—
0
0
113
815
1.45
2.86
3.4
3.0
1.02
1.02
kg/l
0.83
75
516
213
1719
1.37
2.79
4.2
3.5
0.00
3.98
estimate
0.50
37
309
112
811
1.44
2.77
4.6
3.6
0.00
0.00
estimate
0.50
34
300
94
660
1.47
2.72
4.1
4.2
—
—
—
0
0
25
122
2.04
2.69
4.1
12.7
23.50
23.38
mmol/l
0.07
25
116
39
223
1.76
2.63
1.7
1.8
0.29
0.25
mg/l
0.17
18
111
32
172
1.86
2.63
1.4
1.3
—
—
—
0
0
322
2790
1.38
2.59
4.7
3.3
1.30
1.38
mmol/l
3.39
315
2668
29
152
1.90
2.57
28.7
15.7
1.74
1.20
%
1.02
29
152
144
1110
1.37
2.46
2.2
1.9
1.44
1.35
mmol/l
0.59
132
1030
81
564
1.47
2.44
3.0
2.4
—
—
—
0
0
81
564
1.47
2.44
2.9
2.4
—
—
—
0
0
94
674
1.44
2.44
4.1
2.4
—
—
—
0
0
28
148
1.88
2.43
29.7
16.0
0.58
0.67
%
0.77
28
148
9
26
3.40
2.40
1.1
1.2
100.67
112.46
pmol/l
—
9
26
81
566
1.47
2.40
3.0
2.4
—
—
—
0
0
76
526
1.48
2.36
3.1
2.5
—
—
—
0
0
208
1712
1.32
2.25
4.2
3.4
0.00
0.00
estimate
-0.00
35
323
30
167
1.79
2.24
4.7
11.4
0.66
0.60
%
0.44
30
167
23
118
1.93
2.19
32.9
18.6
15.45
16.46
%
0.60
23
112
46
290
1.59
2.19
2.7
5.8
67.17
64.49
e9/l
0.12
21
165
19
91
2.06
2.18
3.4
6.9
37.05
37.00
°c
0.34
19
91
67
460
1.48
2.17
2.4
2.7
343.94
349.64
nmol/l
0.08
67
442
79
561
1.44
2.16
3.0
2.3
—
—
—
0
0
14
59
2.34
2.16
3.3
8.6
1.58
2.82
mmol/l
—
9
26
12
47
2.51
2.14
5.0
15.4
0.92
0.87
%
0.06
12
41
209
1731
1.30
2.13
4.3
3.5
0.00
0.00
estimate
-0.00
36
300
40
248
1.61
2.04
6.2
5.5
0.00
0.07
%
1.02
11
73
414
3793
1.49
2.03
14.6
11.1
21.83
22.94
mg/l
0.30
319
2805
40
249
1.61
2.01
7.3
5.7
0.00
0.07
%
—
10
70
15
70
2.11
1.85
2.3
7.3
—
—
—
0
0
91
682
1.36
1.82
1.3
1.3
—
—
—
0
0
7
22
3.11
1.82
7.3
25.4
106.71
105.06
mmol/l
—
7
16
7
22
3.11
1.82
7.3
25.4
11.71
11.88
mmol/l
—
7
16
8
28
2.80
1.79
1.0
3.3
—
—
—
0
0
6
17
3.45
1.78
1.0
1.1
—
—
—
0
0
119
1399
0.76
1.77
2.4
2.4
—
—
—
0
0
9
188
0.45
1.77
1.0
1.1
—
0.61
—
0
13
40
258
1.55
1.76
6.3
5.4
0.23
0.76
%
1.09
11
82
31
188
1.64
1.75
4.5
12.1
127.65
130.45
g/l
0.22
31
183
16
79
1.99
1.72
3.0
4.8
—
—
—
0
0
23
130
1.75
1.67
3.0
3.2
—
—
—
0
0
10
39
2.51
1.67
1.0
1.1
156.70
249.47
mg/l
—
10
34
9
183
0.47
1.65
1.3
1.5
—
—
—
0
0
20
109
1.81
1.64
6.1
15.2
67.59
72.49
%
0.48
20
109
110
1292
0.77
1.61
2.0
1.9
—
—
—
0
0
5
14
3.48
1.57
1.4
3.0
35.40
34.43
umol/l
—
5
14
5
14
3.48
1.57
1.4
3.0
27.80
27.07
umol/l
—
5
14
12
55
2.14
1.56
3.1
13.6
1.53
1.44
%
0.10
12
48
6
20
2.93
1.53
2.8
1.5
—
—
—
0
0
174
1458
1.25
1.49
1.8
1.7
1.75
1.75
g/l
0.00
92
805
411
3802
1.38
1.49
12.7
8.2
—
—
—
0
0
267
2351
1.23
1.42
4.6
4.0
43.87
31.76
u/l
2.69
257
2281
33
216
1.52
1.39
2.1
1.8
0.00
0.00
estimate
—
7
65
6
22
2.66
1.38
1.0
1.0
—
—
—
0
0
62
458
1.36
1.38
4.6
6.4
7.14
6.93
umol/l
0.05
52
385
77
588
1.32
1.38
9.4
7.5
—
—
—
0
0
9
40
2.20
1.36
3.2
4.7
—
88.38
—
0
13
0
38
0.00
1.34
0.0
1.3
—
216.39
—
0
38
5
17
2.87
1.31
2.4
2.8
2170.00
1460.88
ml
—
5
17
36
244
1.46
1.30
5.3
5.1
0.00
0.62
%
—
7
79
14
74
1.86
1.28
12.4
13.4
25.11
24.18
mmol/l
0.44
14
68
8
34
2.30
1.27
1.1
1.1
—
—
—
0
0
18
104
1.70
1.25
4.1
3.8
2.64
4.81
index
0.51
11
67
11
195
0.54
1.24
1.1
1.1
0.84
0.89
g/l
0.42
11
195
85
669
1.28
1.23
3.6
2.3
19.05
63.48
ng/l
0.71
50
259
63
476
1.32
1.22
4.3
3.3
219.69
1510.72
ng/l
3.14
39
248
94
1090
0.79
1.21
1.9
1.8
—
—
—
0
0
452
4278
1.66
1.19
26.4
17.2
268.89
263.90
e9/l
0.88
435
4141
11
192
0.54
1.19
1.1
1.1
1.42
1.47
g/l
0.31
11
192
19
114
1.64
1.17
1.8
2.0
2.70
3.87
iu/l
—
7
48
17
99
1.69
1.16
2.5
2.4
—
—
—
0
0
452
4282
1.64
1.13
26.3
17.1
4.75
4.68
e12/l
2.06
435
4139
47
346
1.35
1.10
4.0
2.7
14100.00
5019.17
u/l
0.35
11
145
7
31
2.20
1.08
1.0
1.8
8.71
8.45
umol/l
—
7
31
11
57
1.89
1.08
1.1
1.1
—
—
—
0
0
452
4287
1.60
1.05
26.5
17.2
6.96
6.93
e9/l
0.06
435
4138
9
45
1.95
1.03
4.1
2.1
—
—
—
0
0
31
215
1.42
1.03
1.1
1.1
—
—
—
0
0
7
33
2.07
1.03
3.6
1.8
—
—
—
0
0
19
119
1.57
1.01
2.9
5.4
—
—
—
0
0
5
22
2.21
0.99
1.6
1.4
—
—
—
0
0
0
31
0.00
0.95
0.0
1.0
—
—
—
0
0
6
27
2.17
0.92
1.0
1.1
—
—
nmol/l
—
0
0
11
176
0.60
0.91
1.0
1.2
—
—
—
0
0
36
263
1.35
0.90
2.1
2.2
—
15.80
—
0
27
16
99
1.58
0.90
1.1
1.3
389.29
367.24
ug/g
—
7
55
178
1559
1.17
0.89
1.9
1.8
1.48
3.11
u/ml
0.83
29
298
17
108
1.54
0.87
1.5
7.6
24.62
24.43
mmol/l
0.10
17
103
17
108
1.54
0.87
7.0
16.0
66.69
71.51
%
0.41
17
108
15
93
1.58
0.84
1.3
1.1
—
—
—
0
0
8
135
0.57
0.84
1.3
1.7
—
9.04
—
0
7
47
362
1.29
0.83
2.9
2.6
26.13
170.79
u/l
0.54
40
299
14
86
1.59
0.82
1.1
1.1
—
—
—
0
0
28
200
1.38
0.82
6.1
9.6
172.47
330.37
mg/l
1.81
17
162
36
445
0.76
0.80
1.8
1.7
—
—
—
0
0
86
963
0.83
0.79
1.7
1.7
—
—
—
0
0
6
32
1.83
0.79
8.7
5.8
4.00
3.81
mmol/l
—
6
32
10
57
1.71
0.76
1.1
2.7
—
—
—
0
0
19
128
1.46
0.76
2.8
5.0
31.64
10.47
e6/l
0.49
11
86
14
89
1.54
0.73
3.5
6.8
—
—
—
0
0
11
165
0.64
0.72
3.7
4.5
16.94
9.55
umol/l
0.36
11
133
19
130
1.43
0.71
2.8
5.0
1097.17
539.05
e6/l
0.31
12
93
13
187
0.66
0.71
1.4
1.5
—
—
—
0
0
13
187
0.66
0.71
1.5
1.6
—
—
—
0
0
55
443
1.23
0.69
1.3
1.3
—
244.76
—
0
17
7
40
1.70
0.69
2.6
1.3
—
—
—
0
0
10
59
1.65
0.69
1.1
1.1
—
—
—
0
0
65
535
1.20
0.67
1.4
1.6
268.57
424.39
titre
—
7
82
5
27
1.80
0.66
1.2
1.0
—
—
—
0
0
8
47
1.66
0.62
8.3
2.9
8.67
5.92
mmol/l
—
8
39
212
1919
1.13
0.62
3.7
3.7
68.55
66.64
ug/l
0.08
199
1838
5
29
1.68
0.61
1.2
1.1
—
—
—
0
0
13
180
0.69
0.60
1.4
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.2
—
71.86
—
0
21
13
179
0.69
0.59
1.4
1.2
—
—
—
0
0
15
201
0.71
0.59
1.1
1.1
—
25.78
—
0
33
8
52
1.50
0.58
3.6
10.5
5.69
4.98
pmol/l
—
8
52
6
34
1.72
0.58
7.0
5.0
20.94
22.00
ug/l
—
6
34
6
37
1.58
0.54
1.2
1.1
—
—
—
0
0
6
37
1.58
0.54
1.0
1.3
—
—
—
0
0
6
37
1.58
0.54
1.0
1.3
—
—
—
0
0
9
129
0.67
0.52
1.2
1.4
—
—
—
0
0
39
314
1.22
0.52
1.5
1.4
—
—
—
0
0
6
39
1.50
0.51
1.0
1.0
168.50
165.51
g/l
—
6
39
9
63
1.39
0.50
4.7
4.1
3.72
3.20
e9/l
—
9
63
18
132
1.33
0.49
1.2
1.1
—
—
—
0
0
78
673
1.15
0.48
4.2
3.9
2.18
1.47
mg/l
0.53
52
475
12
82
1.43
0.48
1.1
1.2
—
—
—
0
0
14
99
1.38
0.47
1.5
1.6
—
—
—
0
0
7
48
1.42
0.45
1.1
1.1
15.34
32.34
iu/ml
—
7
48
20
152
1.29
0.44
2.4
1.7
22.60
24.03
ng/l
0.13
20
152
22
170
1.27
0.43
1.2
1.3
—
—
—
0
0
13
167
0.75
0.42
1.1
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
11.8
—
—
—
0
0
16
119
1.31
0.41
1.1
1.2
—
—
—
0
0
28
324
0.83
0.40
1.9
2.0
—
—
—
0
0
5
34
1.43
0.39
1.4
1.6
—
—
—
0
0
20
155
1.26
0.39
1.3
1.6
1.27
1.16
g/l
0.93
20
149
9
67
1.31
0.37
1.4
1.4
—
—
—
0
0
6
43
1.36
0.34
3.8
5.3
0.67
0.93
index
—
6
43
133
1210
1.09
0.34
4.3
3.0
0.00
0.00
estimate
0.50
29
274
13
98
1.29
0.31
1.2
2.0
—
—
—
0
0
13
98
1.29
0.31
1.2
2.0
—
—
—
0
0
13
98
1.29
0.31
1.2
2.0
—
—
—
0
0
13
98
1.29
0.31
1.2
2.0
—
—
—
0
0
36
305
1.15
0.31
1.2
1.2
—
—
—
0
0
7
52
1.31
0.30
1.1
1.0
—
—
—
0
0
38
324
1.15
0.30
2.1
2.1
13.33
11.83
iu/l
0.14
24
214
12
90
1.30
0.30
5.8
5.1
2.61
8.03
u/ml
1.63
12
90
59
522
1.11
0.27
2.4
4.4
332.06
316.35
umol/l
0.59
54
498
16
187
0.82
0.27
2.6
2.2
—
—
—
0
0
8
64
1.21
0.27
1.3
1.9
—
—
—
0
0
49
430
1.12
0.26
2.6
2.1
—
—
—
0
0
38
411
0.89
0.26
1.3
1.3
2.16
2.82
u/ml
0.28
33
302
126
1284
0.93
0.26
1.4
1.7
—
—
—
0
0
13
101
1.25
0.26
1.7
1.4
1.67
11.87
u/ml
—
7
85
55
487
1.11
0.25
1.2
1.2
27.77
7.60
u/ml
0.55
21
175
10
76
1.28
0.23
10.5
19.6
12.71
12.13
%
—
10
76
15
173
0.83
0.23
2.1
1.9
32.27
35.83
nmol/l
0.24
15
167
5
40
1.21
0.22
1.2
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
0.00
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
22
243
0.87
0.21
1.2
1.4
254.28
252.27
miu/ml
—
8
122
0
12
0.00
0.21
0.0
4.1
—
15.04
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
91
833
1.07
0.21
7.3
5.4
—
—
—
0
0
40
353
1.11
0.20
1.4
1.3
37.58
138.00
u/ml
3.32
11
128
35
373
0.90
0.20
1.3
1.2
1.80
2.92
u/ml
0.53
25
275
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
50
1.16
0.19
3.8
4.9
36.00
16.21
index
—
6
43
24
261
0.88
0.19
1.4
1.6
—
—
—
0
0
29
253
1.12
0.18
4.3
3.6
—
—
—
0
0
6
75
0.77
0.15
1.8
1.3
—
—
—
0
0
9
75
1.16
0.15
6.6
4.7
—
—
—
0
0
9
76
1.15
0.15
4.9
6.1
4.65
1.73
ug/l
—
9
76
35
313
1.09
0.15
2.1
2.1
4.42
6.28
u/l
1.04
19
194
25
266
0.90
0.14
1.2
1.1
6.21
6.48
u/ml
0.02
19
182
36
375
0.92
0.14
1.3
1.2
0.47
0.81
u/ml
0.66
26
269
23
245
0.90
0.14
1.3
1.1
6.56
0.39
u/ml
0.46
12
132
16
137
1.14
0.13
1.1
1.8
3.94
4.00
iu/ml
—
5
22
17
183
0.90
0.12
2.5
2.2
107.57
108.33
au/ml
—
7
75
92
922
0.96
0.11
4.2
2.8
0.00
0.00
estimate
-0.00
32
262
12
132
0.88
0.11
1.3
1.1
—
—
—
0
0
12
102
1.14
0.10
1.7
1.9
35.15
28.50
u/ml
0.23
12
97
148
1401
1.03
0.10
3.1
3.2
—
—
estimate
—
0
0
42
388
1.05
0.08
1.9
1.4
—
—
—
0
0
7
63
1.08
0.08
2.4
3.3
0.55
0.79
e9/l
—
7
63
23
238
0.93
0.08
2.0
2.0
166.93
177.77
u/ml
0.12
14
118
10
109
0.89
0.08
1.4
1.5
4.06
5.63
ug/l
—
10
102
9
97
0.90
0.06
3.1
2.9
1.51
1.16
g/l
—
9
86
50
469
1.04
0.05
1.7
1.6
—
—
—
0
0
25
230
1.06
0.05
1.2
1.3
—
—
—
0
0
15
156
0.93
0.05
3.3
2.5
55.04
53.30
%
0.17
15
156
105
1034
0.98
0.05
3.1
3.0
—
—
—
0
0
14
146
0.93
0.05
1.8
1.7
4.34
10.34
u/ml
—
5
43
47
441
1.04
0.05
1.7
1.4
319.73
286.58
u/ml
0.09
47
416
38
379
0.97
0.03
1.2
1.3
3.20
6.24
u/ml
1.58
29
296
25
252
0.96
0.03
1.2
1.1
10.69
11.27
u/ml
0.04
17
161
55
523
1.02
0.02
1.3
1.3
9.79
19.08
iu/ml
1.75
11
122
22
207
1.03
0.00
1.2
1.2
—
—
—
0
0
25
236
1.03
0.00
1.1
1.1
—
—
—
0
0
11
108
0.99
0.00
1.0
1.0
19.82
19.40
mmol/l
0.19
11
108
11
108
0.99
0.00
1.0
1.0
—
—
—
0
0
14
132
1.03
0.00
1.6
1.8
—
—
—
0
0
18
176
0.99
0.00
1.3
1.6
—
—
—
0
0
25
244
0.99
0.00
2.7
1.9
—
—
—
0
0
76
734
1.00
0.00
2.1
1.7
—
—
—
0
0
88
853
1.00
0.00
2.7
3.3
63.89
105.88
ug/g
1.78
76
696
13
130
0.97
0.00
1.1
1.2
—
—
—
0
0
7
77
0.88
0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
14.69
—
0
7
0
7
0.00
0.00
0.0
4.6
—
0.44
—
0
7
0
7
0.00
0.00
0.0
1.0
—
13.53
—
0
7
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
285.43
—
0
7
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
16.04
—
0
5
0
6
0.00
-0.00
0.0
3.0
—
4.51
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
21.8
—
14.48
—
0
6
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
254.20
—
0
5
0
8
0.00
-0.00
0.0
3.6
—
139.13
—
0
8
6
63
0.92
-0.00
1.5
2.4
13.65
8.83
mg/l
—
6
58
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
71.86
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
1799.44
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.4
—
29.33
—
0
9
0
5
0.00
-0.00
0.0
2.2
—
0.39
—
0
5
0
9
0.00
-0.00
0.0
3.4
—
5.78
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
85.33
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
32.64
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint F5_PSYCHDEVOTH and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have F5_PSYCHDEVOTH.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: F5_PSYCHDEVOTH – Other and unspecified disorders of psychological development

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data